![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChemCID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C11H15BrN2O3 |
Molar mass | 303.156 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Narcobarbital (Pronarcon) is abarbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative ofpropallylonal and has similarsedative effects. It is still used inveterinary medicine for inducingsurgicalanaesthesia.[2]